CORMEDIX INC.
CRMDCIK 0001410098
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
$187.64M
+1,009.4% YoY
Q1 May 2026
EPS Diluted (TTM)
$2.27
+780.0% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
$33.6M
Q1 May 2026
Cash
$178.09M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
78.45M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.